| |
|
|
|
Aridis Pharmaceuticals Inc  
|
|
3.59 -0.08 (-0.02%) |
09-28 16:00 |
|
Open: |
3.67 |
Pre close: |
3.67 |
Target:
|
4.70
|
|
High: |
3.83 |
Low: |
3.54 |
Resistance:
|
4.02
4.34
|
|
Volume: |
49,024 |
Market Cap: |
53M |
Support:
|
3.51
2.92
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
3.74
 |
MACD |
MACD(12,26):
|
-0.15 |
|
MA(20): |
3.94 |
Signal(12,26,9): |
-0.15 |
|
MA(100): |
5.35 |
Stochastic Oscillator |
%K(14,3):
|
19.24 |
|
MA(250): |
6.17 |
%D(3): |
21.99 |
|
Average Volume(K) |
3-Month: |
236273
|
52-Week |
High:
|
8.50 |
|
10-Days: |
3890 |
Low: |
3.51 |
|
RSI |
RSI(14):
|
37.86 |
Change(%): |
-49.3 |
|
Financials, Statistics and Valuation |
|
EPS |
-2.436 |
Return on Equity (ttm) |
0.0 |
Shares Out. (M) |
11.23 |
|
EPS Est. Current Year |
0.000 |
Return on Assets (ttm) |
-65.0 |
Shares Float (M) |
6.91 |
|
EPS Est. Next Year |
0.000 |
PEG Ratio |
0.00 |
% Held by Insiders |
33.04 |
|
EPS Est. Next Quarter |
0.000 |
Qtrly Rev. Growth |
0.0 |
% Held by Institutions |
13.58 |
|
Forward EPS |
-3.510 |
Gross Profit (p.s.) |
-1.421 |
Shares Short (K) |
17 |
|
Book Value (p.s.) |
-0.860 |
EBITDA (p.s.) |
-1.964 |
P/E |
-1.47 |
|
Sales Per Share |
0.089 |
Qtrly Earnings Growth |
0.00 |
P/BV |
-4.17 |
|
Profit Margin |
0.00 |
Operating Cash Flow
(M) |
-20.48 |
P/S |
40.31 |
|
Operating Margin |
-2240.10 |
Levered Free Cash Flow
(M) |
-8.82 |
P/CF |
-1.97 |
|
|
|
|
|
|
